Teradyne price target raised to $288 from $229 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Teradyne (TER) to $288 from $229 and keeps an Equal Weight rating on the shares. The “blow out” earnings report and sustainability of networking tester demand brings up the firm’s FY27 and FY28 earnings per share estimates, the analyst tells investors in a research note. The firm added that Teradyne’s core business has clearly inflected upward, with compelling bull-case optionality, though the firm noted it remains constructive on the underlying fundamentals.